RecruitingNot ApplicableNCT06588634
The PERSEVERE Study
Sponsor
Inari Medical
Enrollment
200 participants
Start Date
Dec 16, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called FlowTriever System and a procedure called Standard of Care for people with pulmonary embolism and pulmonary thromboembolism. The study is currently recruiting participants at 26 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEFlowTriever System
Mechanical thrombectomy for pulmonary embolism
PROCEDUREStandard of Care
Standard of care treatment for pulmonary embolism
Locations(29)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06588634
Related Trials
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
NCT0658196510 locations
Prognostic Value of 2026 AHA/ACC Clinical Categorization in Acute Pulmonary Embolism Patients Presenting to the Emergency Department
NCT07805616
Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
NCT063861074 locations
Inari VISION Registry
NCT0660054210 locations
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
NCT066952471 location